Supplement × Prescription·contraindicated·Moderate evidence

5-HTP + Rasagiline

Contraindicated Moderate evidence

5-HTP can increase serotonin synthesis and is unsafe with MAO-inhibiting therapy.

From the database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, and the recommendation.

Substances
Pair type
Contraindicated
Evidence
Moderate
Source citations
1
Scope
Supplement × Prescription
Last verified
June 4, 2026
ContraindicatedModerate evidence

What is happening. 5-HTP can increase serotonin synthesis and is unsafe with MAO-inhibiting therapy.

Mechanism. Serotonin precursor loading can interact with MAO inhibition and increase serotonin syndrome risk.

Recommendation. Avoid 5-HTP while taking rasagiline.

Stack Score

How it moves the number.

Effect on the composite score

If both 5-HTP and Rasagiline are in the same stack, this pair applies −25 to your Stack Score (per scored contraindication row).

The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.

Sources

Sources, by evidence tier.

Every claim on this page is cited. PMIDs link straight to PubMed.

Reference material

1
  • 1U.S. National Library of Medicine. Rasagiline tablets US Prescribing Information. 2026.Needs sourceNo link

Check your full routine

One pair was the worked example.

Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.